Phoenix Tissue Repair Competitors and Similar CompaniesClear all
Phoenix Tissue Repair's competitors and similar companies include Immunicum, Bath ASU, Antibe Therapeutics and CTI BioPharma.
 Phoenix Tissue Repair Phoenix Tissue Repair is a company specializing in the development of treatment for recessive dystrophic epidermolysis bullosa. |  Immunicum Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors. |  Antibe Therapeutics Antibe Therapeutics is a biotechnology company that specializes in the treatment of pain and inflammation. |  CTI BioPharma CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. | ||
Founding Date | Founding Date 2017 | Founding Date 2002 | Founding Date 2006 | Founding Date 2009 | Founding Date 1992 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Stockholm, SE HQ Leiden, NL | Locations Corsham, GB HQ | Locations Toronto, CA HQ | Locations Seattle, US HQ Köln, DE |
Employees | Employees 5 | Employees 309% decrease | Employees 975% increase | Employees 44 | Employees 2546% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 121.9 m | Valuation ($) 1.2 b |
Twitter followers | Twitter followers 43 | Twitter followers 611 | Twitter followers 240 | Twitter followers 1.1 k | Twitter followers 152 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 5 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 8.6 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 2.7 | Employee Rating N/A | Employee Rating 3.1 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $7m (FY, 2023) | Revenue (est.) $53.9m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $3.9m (FY, 2023) | Cost of goods $3.5m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit kr3.4m (FY, 2022) | Gross profit N/A | Gross profit $3m (FY, 2023) | Gross profit $50.4m (FY, 2022) |
Net income | Net income N/A | Net income (kr138.8m) (FY, 2022) | Net income N/A | Net income ($19.5m) (FY, 2023) | Net income ($93m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.2m | Total funding raised $ 105m |
For sources of this data, please see the company profile
View Company Profiles
Immunicum
HQ
Stockholm, SE
Employees
30↓ 9% decrease
Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.
View company
Bath ASU
HQ
Corsham, GB
Employees
97↑ 5% increase
Bath ASU (also known as Qualasept) is a pharmaceutical specials manufacturer.
View companyAntibe Therapeutics
HQ
Toronto, CA
Employees
44
Antibe Therapeutics is a biotechnology company that specializes in the treatment of pain and inflammation.
View companyCTI BioPharma
HQ
Seattle, US
Employees
25↓ 46% decrease
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
View company